Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLX) EPS (Weighted Average and Diluted) (2020 - 2025)

Scilex Holding has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$4.6 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 197.46% to -$4.6 in Q4 2025 year-over-year; TTM through Dec 2025 was -$36.45, a 207.34% decrease, with the full-year FY2025 number at -$36.48, down 353.17% from a year prior.
  • EPS (Weighted Average and Diluted) reached -$4.6 in Q4 2025 per SCLX's latest filing, up from -$22.17 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $4.72 in Q4 2024, with the low at -$22.17 in Q3 2025.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.24 (2023), against an average of -$2.51.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 1988.0% in 2024 against a maximum downside of 3936.84% in 2024.
  • Tracing SCLX's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.65 in 2021, then skyrocketed by 80.0% to -$0.13 in 2022, then tumbled by 92.31% to -$0.25 in 2023, then surged by 1988.0% to $4.72 in 2024, then tumbled by 197.46% to -$4.6 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$4.6, -$22.17, and -$7.42 for Q4 2025, Q3 2025, and Q2 2025 respectively.